This finding is important because previous reports showed that genetic ablation of MST1 resulted in the protection against the development of STZ-induced diabetes mellitus in mice [16] via improvement of pancreatic β cell survival, and thus it is essential for studying the effects of XMU-MP-1 treatment in pancreatic β cells, as well as in the STZ-induced diabetes model. Here, MST1 is linked to diabetes mellitus.